新云社 update: China’s National Healthcare Security Administration said on November 14 that JW Therapeutics’ CAR-T therapy relma-cel has been added to the national reimbursement drug list. Before inclusion, relma-cel was priced at 1.29 million yuan per infusion. Ma Jun, director of the Harbin Institute of Hematology and Oncology, said the price has now dropped to below 300,000 yuan per infusion.
China Adds JW Therapeutics’ CAR-T Drug Relma-cel to National Reimbursement List
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
1h ago
Bitcoin falls to two-year low as risk-asset selloff deepens
1h ago
Bitcoin falls to $55K as $1.89B in longs liquidated; $60K turns resistance
1h ago
Bitcoin Drops 8% as Crypto Liquidations Hit $2.38 Billion
1h ago
Bitcoin Falls Below $56K to $55,555, Down 53.8% From Record High
1h ago
Crypto market cap falls nearly $800B in a month, down about 27%
1h ago
Ether Falls to Near $1,550, Down About 35% in Four Weeks




